HomeAORI Home

Aspirus Oncology Research Institute

Aspirus Cancer Care - WI

For more than 30 years, Aspirus has been committed to advancing cancer care through clinical research. Since launching its cancer research program in 1994, Aspirus has provided patients with access to innovative clinical trials and emerging treatment options while contributing to advancements in cancer care nationwide.

Today, the Aspirus Oncology Research Institute (AORI) participates in the National Cancer Institute (NCI) Community Oncology Research Program (NCORP), a national network that brings cutting-edge cancer research to communities across the country. Through this partnership, patients can access clinical trials focused on cancer treatment, prevention, symptom management, survivorship, and cancer care delivery.

As a member of six NCI-funded research groups, AORI helps bring high-quality, clinically relevant studies to patients close to home. These research collaborations connect our communities to groundbreaking discoveries while maintaining the rigorous standards required by the nation's leading cancer research organizations.

Since becoming part of Cancer Research of Wisconsin and Northern Michigan (CROWN) in 2018, AORI has enrolled hundreds of participants in clinical trials, helping expand access to innovative therapies and improve cancer outcomes for future generations. 

30+
Years of Oncology Research
Hundreds
Research Participants Enrolled
NCI
Supported Clinical Trials

Why Clinical Research Matters

Access Innovative Treatments

Innovative Treatments

Explore promising therapies and treatment approaches through clinical trials.

Care Close to Home

Care Close to Home

Participate in research without traveling to large academic medical centers.

Expert Research Team

Receive support from experienced physicians, research nurses, and coordinators.

 

Research Leadership

The Aspirus Oncology Research Institute is invested in oncology research through strong physician leadership. AORI Principal Investigator Dr. Andrew Huang serves on several national oncology research committees and helps advance innovative cancer clinical trials.

Dr. Andrew Huang


Dr. Andrew Huang
AORI Principal Investigator

Through participation in national oncology research networks, Dr. Huang helps bring leading-edge clinical research opportunities to patients throughout the region.

View Profile

National Research Committee Participation

  • 2025–Present ECOG-ACRIN Genitourinary Community Oncology (Committee Member)
  • 2024–Present NRG Oncology Radiation Oncology Committee (General Member)
  • 2024–Present NRG Oncology Genitourinary Cancer Committee (General Member)
  • 2024–Present NRG Oncology Developmental Therapeutics RT (Subcommittee)
  • 2023–Present National Cancer Institute Head and Neck Steering Committee